Oraya Therapeutics (Newark, CA) an early-stage medical device company focused on radiation treatment of age related macular degeneration, closed a $42M Series C financing. Participants include Domain Associates, Scale Venture Partners, Essex Woodlands Health Ventures and Synergy Life Partners.